AlphaCentric Advisors »

Arrivent Biopharma shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Arrivent Biopharma shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.5M 83k 17.86

More positions owned by AlphaCentric Advisors

Pfizer (PFE)
Rithm Capital Corp Com New (RITM)
Harmony Biosciences Hldgs In (HRMY)
United Therapeutics Corporation (UTHR)
Pacira Pharmaceuticals (PCRX)
BioCryst Pharmaceuticals (BCRX)
Galapagos Nv Spon Adr (GLPG)
Argenx Se Sponsored Adr (ARGX)
Two Harbors Inventment Corpo Note 6.250% 1/1
Inari Medical Ord (NARI)
Docgo (DCGO)
Beigene Sponsored Adr (BGNE)
Ellington Financial Inc ellington financ (EFC)
Axsome Therapeutics (AXSM)
MGIC Investment (MTG)

View all positions for AlphaCentric Advisors

Top funds holding Arrivent Biopharma

AlphaCentric Advisors
Bank of New York Mellon
Bnp Paribas Arbitrage, Snc
Amalgamated Bank

View all funds holding Arrivent Biopharma